Functional MRI in the early diagnosis of Alzheimer's disease: Is it time to refocus?

Expert Review of Neurotherapeutics

Volumn 8, Issue 2, 2008, Pages 169-175

  Prince, Steven E ^a   Woo, Shoshana ^b   Doraiswamy, P Murali ^a   Petrella, Jeffrey R ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; BIOLOGICAL MARKER; GLUCOSE;

ALZHEIMER DISEASE; BRAIN ATROPHY; BRAIN FUNCTION; CEREBROSPINAL FLUID; CLINICAL FEATURE; COGNITION; COST BENEFIT ANALYSIS; DISEASE COURSE; EDITORIAL; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENE MUTATION; GLUCOSE METABOLISM; HOME CARE; HUMAN; INTERVENTION STUDY; MEDICAL RESEARCH; MEMORY DISORDER; PATIENT MONITORING; POSITRON EMISSION TOMOGRAPHY; POSTHUMOUS CARE; PREVALENCE;

ALZHEIMER DISEASE; EARLY DIAGNOSIS; HUMANS; MAGNETIC RESONANCE IMAGING; TEMPORAL LOBE; TIME FACTORS;

EID: 39549104761     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/14737175.8.2.169     Document Type: Editorial

References (59)

1. Petrella JR, Coleman RE, Doraiswamy PM. Neuroimaging and early diagnosis of Alzheimer disease: a look to the future. Radiology 226, 315-336 (2003).
2. Doraiswamy PM. Interventions for mild cognitive impairment and Alzheimer disease: new strategies, new hope. Am. J. Geriatr. Psychiatr. 11, 120-122 (2003).
3. Small GW, Rabins PV, Barry PP et al. Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society. JAMA 278, 1363-1371 (1997).
4. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34, 939-944 (1984).
5. Petersen RC. Aging, mild cognitive impairment, and Alzheimer's disease. Neurol. Clin. 18, 789-806 (2000).
6. Doraiswamy PM, Xiong GL. Pharmacological strategies for the prevention of Alzheimer's disease. Expert Opin. Pharmacother. 7, 1-10 (2006).
7. Petrella JR, Prince SE, Wang L, Hellegers C, Doraiswamy PM. Prognostic value of posteromedial cortex deactivation in mild cognitive impairment. PLoS ONE 2, E1104 (2007).
8. Dubois B, Feldman HH, Jacova C et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDSADRDA criteria. Lancet Neurol. 6, 734-746 (2007).
9. Jack CR Jr, Petersen RC, O'Brien PC, Tangalos EG. MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease. Neurology 42, 183-188 (1992).
10. Jack CR Jr, Petersen RC, Xu Y et al. Rates of hippocampal atrophy correlate with change in clinical status in aging and AD. Neurology 55, 484-489 (2000).
11. de Leon MJ, Convit A, George AE et al. In vivo structural studies of the hippocampus in normal aging and in incipient Alzheimer's disease. Ann. NY Acad. Sci. 777, 1-13 (1996).
12. De Toledo-Morrell L, Goncharova I, Dickerson B, Wilson RS, Bennett DA. From healthy aging to early Alzheimer's disease: in vivo detection of entorhinal cortex atrophy. Ann. NY Acad. Sci. 911, 240-253 (2000).
13. Du AT, Schuff N, Zhu XP et al. Atrophy rates of entorhinal cortex in AD and normal aging. Neurology 60, 481-486 (2003).
14. Ramani A, Jensen JH, Helpern JA. Quantitative MR imaging in Alzheimer disease. Radiology 241, 26-44 (2006).
15. Gusnard DA, Raichle ME. Searching for a baseline: functional imaging and the resting human brain. Nat. Rev. Neurosci. 2, 685-694 (2001).
16. Raichle ME, Gusnard DA. Appraising the brain's energy budget. Proc. Natl Acad. Sci. USA 99, 10237-10239 (2002).
17. Raichle ME, MacLeod AM, Snyder AZ, Powers WJ, Gusnard DA, Shulman GL. A default mode of brain function. Proc. Natl Acad. Sci. USA 98, 676-682 (2001).
18. Minoshima S, Frey KA, Koeppe RA, Foster NL, Kuhl DE. A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J. Nucl. Med. 36, 1238-1248 (1995).
19. Minoshima S, Giordani B, Berent S, Frey KA, Foster NL, Kuhl DE. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann. Neurol. 42, 85-94 (1997).
20. Alexander GE, Chen K, Pietrini P, Rapoport SI, Reiman EM. Longitudinal PET evaluation of cerebral metabolic decline in dementia: a potential outcome measure in alzheimer's disease treatment studies. Am. J. Psychiatr. 159, 738-745 (2002).
21. Reiman EM, Chen K, Alexander GE et al. Correlations between apolipoprotein E epsilon4 gene dose and brain-imaging measurements of regional hypometabolism. Proc. Natl Acad. Sci. USA 102, 8299-8302 (2005).
22. Buckner RL, Snyder AZ, Shannon BJ et al. Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory. J. Neurosci. 25, 7709-7717 (2005).
23. Lustig C, Snyder AZ, Bhakta M et al. Functional deactivations: change with age and dementia of the Alzheimer type. Proc. Natl Acad. Sci. USA 100, 14504-14509 (2003).
24. Petrella JR, Wang L, Krishnan S et al. Cortical deactivation in mild cognitive impairment: high-field-strength functional MR imaging. Radiology 245, 224-235 (2007).
25. Greicius MD, Srivastava G, Reiss AL, Menon V. Default-mode network activity distinguishes Alzheimer's disease from healthy aging: evidence from functional MRI. Proc. Natl Acad. Sci. USA 101, 4637-4642 (2004).
26. Rombouts SA, Barkhof F, Goekoop R, Stam CJ, Scheltens P. Altered resting state networks in mild cognitive impairment and mild Alzheimer's disease: an fMRI study. Hum. Brain Mapp. 26, 231-239 (2005).
27. Scoville WB, Milner B. Loss of recent memory after bilateral hippocampal lesions. J. Neurochem. 20, 11-21 (1957).
28. Zola-Morgan S, Squire LR, Mishkin M. The neuroanatomy of amnesia: amygdalahippocampus versus temporal stem. Science 218, 1337-1339 (1982).
29. Prince SE, Daselaar SM, Cabeza R. Neural correlates of relational memory: successful encoding and retrieval of semantic and perceptual associations. J. Neurosci. 25, 1203-1210 (2005).
30. Ranganath C, D'Esposito M. Medial temporal lobe activity associated with active maintenance of novel information. Neuron 31, 865-873 (2001).
31. Krishnan S, Slavin MJ, Tran TT, Doraiswamy PM, Petrella JR. Accuracy of spatial normalization of the hippocampus: implications for fMRI research in memory disorders. Neuroimage 31, 560-571 (2006).
32. Rombouts SA, Barkhof F, Veltman DJ et al. Functional MR imaging in Alzheimer's disease during memory encoding. AJNR Am. J. Neuroradiol. 21, 1869-1875 (2000).
33. Johnson SC, Schmitz TW, Moritz CH et al. Activation of brain regions vulnerable to Alzheimer's disease: the effect of mild cognitive impairment. Neurobiol. Aging 27, 1604-1612 (2006).
34. Petrella JR, Krishnan S, Slavin MJ, Tran TT, Murty L, Doraiswamy PM. Mild cognitive impairment: evaluation with 4-T functional MR imaging. Radiology 240, 177-186 (2006).
35. Johnson SC, Baxter LC, Susskind-Wilder L, Connor DJ, Sabbagh MN, Caselli RJ. Hippocampal adaptation to face repetition in healthy elderly and mild cognitive impairment. Neuropsychologia 42, 980-989 (2004).
36. Sperling RA, Bates JF, Chua EF et al. fMRI studies of associative encoding in young and elderly controls and mild Alzheimer's disease. J. Neurol. Neurosurg. Psychiatr. 74, 44-50 (2003).
37. Celone KA, Calhoun VD, Dickerson BC et al. Alterations in memory networks in mild cognitive impairment and Alzheimer's disease: an independent component analysis. J. Neurosci. 26, 10222-10231 (2006).
38. Machulda MM, Ward HA, Borowski B et al. Comparison of memory fMRI response among normal, MCI, and Alzheimer's patients. Neurology 61, 500-506 (2003).
39. Pariente J, Cole S, Henson R et al. Alzheimer's patients engage an alternative network during a memory task. Ann. Neurol. 58, 870-879 (2005).
40. Kircher T, Weis S, Freymann K et al. Hippocampal activation in MCI patients is necessary for successful memory encoding. J. Neurol. Neurosurg. Psychiatr. 78(8), 812-818 (2007).
41. Dickerson BC, Salat DH, Bates JF et al. Medial temporal lobe function and structure in mild cognitive impairment. Ann. Neurol. 56, 27-35 (2004).
42. Dickerson BC, Salat DH, Greve DN et al. Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD. Neurology 65, 404-411 (2005).
43. Hämäläinen A, Pihlajamäki M, Tanila H et al. Increased fMRI responses during encoding in mild cognitive impairment. Neurobiol. Aging 28(12), 1889-1903 (2006).
44. Bookheimer SY, Strojwas MH, Cohen MS et al. Patterns of brain activation in people at risk for Alzheimer's disease. N. Engl. J. Med. 343, 450-456 (2000).
45. Johnson SC, Schmitz TW, Trivedi MA et al. The influence of Alzheimer disease family history and apolipoprotein E epsilon4 on mesial temporal lobe activation. J. Neurosci. 26, 6069-6076 (2006).
46. Mason MF, Norton MI, Van Horn JD, Wegner DM, Grafton ST, Macrae CN. Wandering minds: the default network and stimulus-independent thought. Science 315, 393-395 (2007).
47. Gusnard DA, Raichle ME, Raichle ME. Searching for a baseline: functional imaging and the resting human brain. Nat. Rev. Neurosci. 2, 685-694 (2001).
48. Mazoyer B, Zago L, Mellet E et al. Cortical networks for working memory and executive functions sustain the conscious resting state in man. Brain Res. Bull. 54, 287-298 (2001).
49. Laureys S, Lemaire C, Maquet P, Phillips C, Franck G. Cerebral metabolism during vegetative state and after recovery to consciousness. J. Neurol. Neurosurg. Psychiatr. 67, 121 (1999).
50. Daselaar SM, Prince SE, Cabeza R. When less means more: deactivations during encoding that predict subsequent memory. Neuroimage 23, 921-927 (2004).
51. McKiernan KA, Kaufman JN, Kucera-Thompson J, Binder JR. A parametric manipulation of factors affecting task-induced deactivation in functional neuroimaging. J. Cogn. Neurosci.15, 394-408 (2003).
52. Sorg C, Riedl V, Muhlau M et al. Selective changes of resting-state networks in individuals at risk for Alzheimer's disease. Proc. Natl Acad. Sci. USA 104, 18760-18765 (2007).
53. Wang L, Zang Y, He Y et al. Changes in hippocampal connectivity in the early stages of Alzheimer's disease: evidence from resting state fMRI. Neuroimage 31, 496-504 (2006).
54. Greicius MD, Krasnow B, Reiss AL, Menon V. Functional connectivity in the resting brain: a network analysis of the default mode hypothesis. Proc. Natl Acad. Sci. USA 100, 253-258 (2003).
55. Delis D, Kramer J, Kaplan E, Ober B. The California Verbal Learning Test-Research Edition. Psychological Corp., NY, USA (1987).
56. Xu G, Antuono PG, Jones J et al. Perfusion fMRI detects deficits in regional CBF during memory-encoding tasks in MCI subjects. Neurology 69, 1650-1656 (2007).
57. Du AT, Jahng GH, Hayasaka S et al. Hypoperfusion in frontotemporal dementia and Alzheimer disease by arterial spin labeling MRI. Neurology 67, 1215-1220 (2006).
58. Fox MD, Raichle ME. Spontaneous fluctuations in brain activity observed with functional magnetic resonance imaging. Nat. Rev. Neurosci. 8, 700-711 (2007).
59. Fox MD, Snyder AZ, Vincent JL, Corbetta M, Van Essen DC, Raichle ME. The human brain is intrinsically organized into dynamic, anticorrelated functional networks. Proc. Natl Acad. Sci. USA 102, 9673-9678 (2005).